Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 5 records per page: next > | last >>
pages: 1 2 3 4 5 presentations: 1 to 50 of 202
SYMPOSIUM: BREAST IS BEST, BUT IT'S A VIRAL MILKSHAKE!
THE INFANT GUT: A GREAT DEFENSE SYSTEM?   (ABSTRACT 52)
Andrew Prendergast
Queen Mary University of London, London , United Kingdom
from CROI 2018 on March 5, 2018 4:00 PM-6:00 PM
SYMPOSIUM: BREAST IS BEST, BUT IT'S A VIRAL MILKSHAKE!
MOTHER-TO-CHILD TRANSMISSION OF HTLV-1   (ABSTRACT 53)
Antoine Gessain
Institut Pasteur, Paris, France
from CROI 2018 on March 5, 2018 4:00 PM-6:00 PM
SYMPOSIUM: BREAST IS BEST, BUT IT'S A VIRAL MILKSHAKE!
CAN WE ELIMINATE BREASTMILK TRANSMISSION OF HIV?   (ABSTRACT 54)
Ameena Goga
South African Medical Research Council, Cape Town, South Africa
from CROI 2018 on March 5, 2018 4:00 PM-6:00 PM
SYMPOSIUM: BREAST IS BEST, BUT IT'S A VIRAL MILKSHAKE!
ART IN BREASTMILK: DEFINING THE RISK-BENEFIT RATIO   (ABSTRACT 55)
Catriona Waitt
University of Liverpool, Liverpool, Merseyside, United Kingdom
from CROI 2018 on March 5, 2018 4:00 PM-6:00 PM
SYMPOSIUM: OBSTACLES TO THE GLOBAL CONTROL OF TUBERCULOSIS
THE GLOBAL BURDEN OF TUBERCULOSIS AND MODELING CONTROL STRATEGIES   (ABSTRACT 56)
Nimalan Arinaminpathy
Imperial College London, London, United Kingdom
from CROI 2018 on March 5, 2018 4:00 PM-6:00 PM
SYMPOSIUM: OBSTACLES TO THE GLOBAL CONTROL OF TUBERCULOSIS
USING WHOLE GENOME SEQUENCING TO BETTER UNDERSTAND TB TRANSMISSION DYNAMICS   (ABSTRACT 57)
Neel R Gandhi
Emory University, Atlanta, GA, USA
from CROI 2018 on March 5, 2018 4:00 PM-6:00 PM
SYMPOSIUM: OBSTACLES TO THE GLOBAL CONTROL OF TUBERCULOSIS
UNDIAGNOSED TUBERCULOSIS: PROMISE FOR PREVENTION   (ABSTRACT 58)
Neil A Martinson
Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg., Soweto, Gauteng, South Africa
from CROI 2018 on March 5, 2018 4:00 PM-6:00 PM
SYMPOSIUM: OBSTACLES TO THE GLOBAL CONTROL OF TUBERCULOSIS
NEW DEVELOPMENTS IN THE MANAGEMENT OF DRUG-RESISTANT TUBERCULOSIS   (ABSTRACT 59)
Serena Koenig
Brigham and Women's Hospital, Boston, MA, USA
from CROI 2018 on March 5, 2018 4:00 PM-6:00 PM
SYMPOSIUM: STOP IT NOW: TARGETING EARLY INFECTION EVENTS
MECHANISMS OF EARLY CD8+ T CELL CONTROL   (ABSTRACT 48)
Jonah Sacha
Oregon Health & Science University, Portland, OR, USA
from CROI 2018 on March 5, 2018 4:00 PM-6:00 PM
SYMPOSIUM: STOP IT NOW: TARGETING EARLY INFECTION EVENTS
EARLY BROADLY NEUTRALIZING ANTIBODY TREATMENT LEADING TO T-CELL CONTROL   (ABSTRACT 49)
Malcolm Martin
NIAID, NIH, Bethesda, MD, USA
from CROI 2018 on March 5, 2018 4:00 PM-6:00 PM
SYMPOSIUM: STOP IT NOW: TARGETING EARLY INFECTION EVENTS
ANTI-ΑLPHA-4/ΒETA-7 ANTIBODY-MEDIATED CONTROL: UNDERSTANDING THE MECHANISM   (ABSTRACT 50)
James Arthos
NIH, Bethesda, MD, USA
from CROI 2018 on March 5, 2018 4:00 PM-6:00 PM
SYMPOSIUM: STOP IT NOW: TARGETING EARLY INFECTION EVENTS
EARLY INTERVENTION THERAPIES IN HUMANS: ART, ANTIBODIES, AND VACCINES   (ABSTRACT 51)
Eugène Kroon
Thai Red Cross AIDS Research Centre, Bangkok, Thailand
from CROI 2018 on March 5, 2018 4:00 PM-6:00 PM
SYMPOSIUM: STRATEGIES FOR IMPROVING THE US CARE CASCADE: CONFRONTING A FRAGMENTED HEALTH SYSTEM
THE EVOLVING HIV EPIDEMIC IN THE UNITED STATES   (ABSTRACT 60)
Carlos del Rio
Emory University, Atlanta, GA, USA
from CROI 2018 on March 5, 2018 4:00 PM-6:00 PM
SYMPOSIUM: STRATEGIES FOR IMPROVING THE US CARE CASCADE: CONFRONTING A FRAGMENTED HEALTH SYSTEM
HIV TESTING AND LINKAGE: THE GATEWAY TO TREATMENT AND PREVENTION   (ABSTRACT 61)
Hyman Scott
San Francisco Department of Public Health, San Francisco, CA, USA
from CROI 2018 on March 5, 2018 4:00 PM-6:00 PM
SYMPOSIUM: STRATEGIES FOR IMPROVING THE US CARE CASCADE: CONFRONTING A FRAGMENTED HEALTH SYSTEM
HIV CARE ENGAGEMENT: MAXIMIZING INDIVIDUAL AND POPULATION HEALTH   (ABSTRACT 62)
Michael J Mugavero
University of Alabama at Birmingham, Birmingham, AL, USA
from CROI 2018 on March 5, 2018 4:00 PM-6:00 PM
SYMPOSIUM: STRATEGIES FOR IMPROVING THE US CARE CASCADE: CONFRONTING A FRAGMENTED HEALTH SYSTEM
SYSTEMS OF CARE FOR VULNERABLE POPULATIONS IN THE UNITED STATES   (ABSTRACT 63)
Julia C Dombrowski
University of Washington, Seattle, WA, USA
from CROI 2018 on March 5, 2018 4:00 PM-6:00 PM
SYMPOSIUM: LIFE EXPECTANCY AT 25
SYMPOSIUM CONVENER
Peter W. Hunt
University of California San Francisco, San Francisco, CA, USA
from CROI 2018 on March 6, 2018 4:00 PM-6:00 PM
SYMPOSIUM: LIFE EXPECTANCY AT 25
LIFE EXPECTANCY IN THE MODERN ART ERA   (ABSTRACT 102)
Caroline Sabin
University College London, London, United Kingdom
from CROI 2018 on March 6, 2018 4:00 PM-6:00 PM
SYMPOSIUM: LIFE EXPECTANCY AT 25
IMPACT OF PHYSICAL AND MENTAL COMORBIDITIES ON LIFE EXPECTANCY   (ABSTRACT 103)
Keri N Althoff
Johns Hopkins University, Baltimore, MD, USA
from CROI 2018 on March 6, 2018 4:00 PM-6:00 PM
SYMPOSIUM: LIFE EXPECTANCY AT 25
INFLAMMATION AND DISEASE RISK AMONG HIV-SEROPOSITIVE INDIVIDUALS   (ABSTRACT 104)
Jason V Baker
HCMC / University of Minnesota, Minneapolis, MN, USA
from CROI 2018 on March 6, 2018 4:00 PM-6:00 PM
SYMPOSIUM: LIFE EXPECTANCY AT 25
QUESTIONS AND ANSWERS
from CROI 2018 on March 6, 2018 4:00 PM-6:00 PM
SYMPOSIUM: MOLECULAR MACHINES
SYMPOSIUM CONVENER
Zandrea Ambrose
University of Pittsburgh, Pittsburgh, PA, USA
from CROI 2018 on March 6, 2018 4:00 PM-6:00 PM
SYMPOSIUM: MOLECULAR MACHINES
HIV ENV: STRUCTURE, FUNCTION, AND INHIBITION THEREOF   (ABSTRACT 98)
Peter D Kwong
NIH, Bethesda, MD, USA
from CROI 2018 on March 6, 2018 4:00 PM-6:00 PM
SYMPOSIUM: MOLECULAR MACHINES
ARCHITECTURE OF THE HIV-1 REVERSE TRANSCRIPTASE INITIATION COMPLEX   (ABSTRACT 99)
Elisabetta Viani Puglisi
Stanford University, Stanford, CA, USA
from CROI 2018 on March 6, 2018 4:00 PM-6:00 PM
SYMPOSIUM: MOLECULAR MACHINES
STRUCTURE AND MECHANISM OF THE SAMHD1 HIV-1 RESTRICTION FACTOR   (ABSTRACT 100)
Ian Anthony Taylor
Francis Crick Institute, London, United Kingdom
from CROI 2018 on March 6, 2018 4:00 PM-6:00 PM
SYMPOSIUM: MOLECULAR MACHINES
STRUCTURE AND MECHANISM OF VPS4, THE ENZYME THAT DRIVES HIV BUDDING   (ABSTRACT 101)
Christopher P Hill
University of Utah, Salt Lake City, UT, USA
from CROI 2018 on March 6, 2018 4:00 PM-6:00 PM
SYMPOSIUM: PrEP WORKS, NOW WHAT?
THE INTERSECTION OF PREP AND SEXUALLY TRANSMITTED INFECTIONS   (ABSTRACT 105)
Julia A Schillinger
US Centers for Disease Control and Prevention, New York, NY, USA
from CROI 2018 on March 6, 2018 4:00 PM-6:00 PM
SYMPOSIUM: PrEP WORKS, NOW WHAT?
IMPACT OF PREP ON HIV INCIDENCE   (ABSTRACT 106)
Roel Coutinho
University Medical Center Utreecht, Utrecht, Netherlands
from CROI 2018 on March 6, 2018 4:00 PM-6:00 PM
SYMPOSIUM: PrEP WORKS, NOW WHAT?
FIVE CONTROVERSIES IN PREP SCALE UP   (ABSTRACT 107)
Linda-Gail Bekker
University of Cape Town, Cape Town, South Africa
from CROI 2018 on March 6, 2018 4:00 PM-6:00 PM
SYMPOSIUM: PrEP WORKS, NOW WHAT?
TAKING THE LEAP IN PREP SCALE-UP: A GOOD TYPE OF CHALLENGE   (ABSTRACT 108)
Nelly R. Mugo
Kenya Medical Research Institute, Nairobi, Kenya
from CROI 2018 on March 6, 2018 4:00 PM-6:00 PM
SYMPOSIUM: ART: THE NEXT 25 YEARS
SYMPOSIUM CONVENER
Eric Arts
Western University, London, Ontario, Canada
from CROI 2018 on March 7, 2018 4:00 PM-6:00 PM
SYMPOSIUM: ART: THE NEXT 25 YEARS
INTEGRATING NEW ANTIRETROVIRAL THERAPIES   (ABSTRACT 159)
Chloe Orkin
Barts Health NHS Trust, London, United Kingdom
from CROI 2018 on March 7, 2018 4:00 PM-6:00 PM
SYMPOSIUM: ART: THE NEXT 25 YEARS
BROADLY NEUTRALIZING ANTIBODIES FOR HIV PREVENTION AND TREATMENT:DREAM OR PIPE DREAM?   (ABSTRACT 160)
Daniel R Kuritzkes
Brigham and Women's Hospital/Harvard Medical School, Cambridge, MA, USA
from CROI 2018 on March 7, 2018 4:00 PM-6:00 PM
SYMPOSIUM: ART: THE NEXT 25 YEARS
ANTIRETROVIRAL THERAPY IN CHILDREN: PRESENT CHALLENGES, FUTURE OPPORTUNITIES   (ABSTRACT 161)
Helena Rabie
University of Stellenbosch, Cape Town, South Africa
from CROI 2018 on March 7, 2018 4:00 PM-6:00 PM
SYMPOSIUM: ART: THE NEXT 25 YEARS
TRANSITIONING TO NEW GENERIC ANTIRETROVIRALS IN SUB-SAHARAN AFRICA   (ABSTRACT 162)
Tendani Gaolathe
Botswana-Harvard AIDS Institute, Gaborone, Botswana
from CROI 2018 on March 7, 2018 4:00 PM-6:00 PM
SYMPOSIUM: EMERGING PRIORITIES IN LIVER DISEASE
THE OPIOID EPIDEMIC AND INFECTIOUS DISEASES: A PUBLIC HEALTH CRISIS   (ABSTRACT 163)
Sally Lynn Hodder
West Virginia University, Morgantown, WV, USA
from CROI 2018 on March 7, 2018 4:00 PM-6:00 PM
SYMPOSIUM: EMERGING PRIORITIES IN LIVER DISEASE
GLOBAL ELIMINATION OF HEPATITIS C   (ABSTRACT 164)
Jordan J Feld
Toronto General Hospital, Toronto, ON, Canada
from CROI 2018 on March 7, 2018 4:00 PM-6:00 PM
SYMPOSIUM: EMERGING PRIORITIES IN LIVER DISEASE
THE RISING CHALLENGE OF LIVER CANCER   (ABSTRACT 165)
Massimo Giuseppe Colombo
Humanitas Hospital Rozzano, Milan, Italy
from CROI 2018 on March 7, 2018 4:00 PM-6:00 PM
SYMPOSIUM: EMERGING PRIORITIES IN LIVER DISEASE
EXPANDING HOPE: ORGAN TRANSPLANTS FROM DONORS WITH HIV OR HCV INFECTION   (ABSTRACT 166)
Christine Durand
Johns Hopkins University School of Medicine, Baltimore, MD, USA
from CROI 2018 on March 7, 2018 4:00 PM-6:00 PM
SYMPOSIUM: MULTIDRUG-RESISTANT TB (MDR-TB): THE GOOD, THE BAD, AND THE UGLY
MDR-TB EPIDEMIOLOGY AND TRANSMISSION DYNAMICS
N. Sarita Shah
Centers for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2017 on February 14, 2017 4:00 PM-6:00 PM
SYMPOSIUM: MULTIDRUG-RESISTANT TB (MDR-TB): THE GOOD, THE BAD, AND THE UGLY
EMERGING TREATMENT ISSUES IN MDR-TB
Francesca Conradie
University of the WItswatersrand, Johannesburg, South Africa
from CROI 2017 on February 14, 2017 4:00 PM-6:00 PM
SYMPOSIUM: MULTIDRUG-RESISTANT TB (MDR-TB): THE GOOD, THE BAD, AND THE UGLY
NEW DIAGNOSTIC TECHNOLOGIES FOR MDR-TB
Catharina C Boehme
Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland
from CROI 2017 on February 14, 2017 4:00 PM-6:00 PM
SYMPOSIUM: MULTIDRUG-RESISTANT TB (MDR-TB): THE GOOD, THE BAD, AND THE UGLY
THE CHALLENGES OF TREATING MDR-TB IN CHILDREN
H. Simon Schaaf
Stellenbosch University, Cape Town, South Africa
from CROI 2017 on February 14, 2017 4:00 PM-6:00 PM
SYMPOSIUM: MULTIDRUG-RESISTANT TB (MDR-TB): THE GOOD, THE BAD, AND THE UGLY
QUESTIONS AND ANSWERS
from CROI 2017 on February 14, 2017 4:00 PM-6:00 PM
SYMPOSIUM: STRANGERS IN THE NIGHT: CHALLENGES AND OPPORTUNITIES IN STI CONTROL
VAGINAL MICROBIOME AND SUSCEPTIBILITY TO HIV
R. Scott McClelland
University of Washington, Seattle, WA, USA
from CROI 2017 on February 14, 2017 4:00 PM-6:00 PM
SYMPOSIUM: STRANGERS IN THE NIGHT: CHALLENGES AND OPPORTUNITIES IN STI CONTROL
ANTIBIOTIC PROPHYLAXIS FOR STIs: PROMISES OR PERILS
Jean-Michel Molina
Hôpital St Louis, Paris, France
from CROI 2017 on February 14, 2017 4:00 PM-6:00 PM
SYMPOSIUM: STRANGERS IN THE NIGHT: CHALLENGES AND OPPORTUNITIES IN STI CONTROL
SYPHILIS IN THE ERA OF TREATMENT AS PREVENTION AND PRE-EXPOSURE PROPHYLAXIS
Matthew R Golden
University of Washington, Seattle, WA, USA
from CROI 2017 on February 14, 2017 4:00 PM-6:00 PM
SYMPOSIUM: STRANGERS IN THE NIGHT: CHALLENGES AND OPPORTUNITIES IN STI CONTROL
SCALE-UP OF POINT-OF-CARE TESTS FOR SEXUALLY TRANSMISSIBLE INFECTIONS
Rebecca J Guy
Kirby Institute, University of New South Wales, Sydney, Australia
from CROI 2017 on February 14, 2017 4:00 PM-6:00 PM
SYMPOSIUM: VISIONS OF HIV CURE
VISUALIZING PERSISTENT HIV IN CLINICAL SAMPLES
Daniel E Kaufmann
University of Montreal, Montreal, Canada
from CROI 2017 on February 14, 2017 4:00 PM-6:00 PM
SYMPOSIUM: VISIONS OF HIV CURE
CHARACTERIZING HIV EXPRESSION IN VIVO
Mary F Kearney
National Cancer Institute, National Institutes of Health, Frederick, MD, USA
from CROI 2017 on February 14, 2017 4:00 PM-6:00 PM
<< first | < prev page: of 5 records per page: next > | last >>
pages: 1 2 3 4 5 presentations: 1 to 50 of 202